Nasdaq agrx.

Investor Relations. Agile Therapeutics® is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet needs of today’s women. Our product and product candidates are designed to offer women more freedom and flexibility through additional contraceptive options.AGRX Sales Forecast. Next quarter’s sales forecast for AGRX is $9.20M with a range of $9.20M to $9.20M. The previous quarter’s sales results were $6.66M. AGRX beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 46.22% of the time in the same period.Nov 19, 2023 · NASDAQ:AGRX opened at $2.06 on Friday. The stock has a market capitalization of $5.17 million, a P/E ratio of -0.15 and a beta of 1.81. The company has a 50 day moving average price of $1.96 and a 200 day moving average price of $2.79. Agile Therapeutics has a fifty-two week low of $1.65 and a fifty-two week high of $16.00. See the latest Agile Therapeutics Inc stock price (AGRX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.PRINCETON, N.J., May 22, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the pricing of its ...

The principal risks of investing in the Fund are: Market Risk. The market values of the Fund’s investments, and therefore the value of the Fund’s shares, will go up and down, sometimes rapidly or unpredictably. Market risk may affect a single issuer, industry or section of the economy, or it may affect the market as a whole.PRINCETON, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it has received a notification letter from the ...Apr 9, 2021 · On Mar. 31, he reported buying 10,000 shares at an average price of $20.17. This case of insider buying is a personal investment of over $200,000. Wall Street also thinks that the shares are ...

Agile Therapeutics, Inc. (AGRX) REPORT OVERVIEW Agile Therapeutics' Recent Financial Performance Agile Therapeutics is expected to report earnings on March 14th, 2018.

Agile Therapeutics (NASDAQ: NASDAQ: AGRX) is a women’s healthcare company focused on patch-based contraceptive options. Their lead product, Twirla, is a once-a-week contraceptive patch ...Agile Therapeutics, Inc. (AGRX.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Agile Therapeutics, Inc. | Nasdaq: AGRX ...Track Agile Therapeutics Inc (AGRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable …PRINCETON, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women’s healthcare company, today announced that on December 11, 2018, it met with the U.S. Food ...... Nasdaq Listing Rule 5635(c)(4). GlobeNewswire Oct 4, 2023 1:30pm. Agile Therapeutics (NASDAQ: AGRX) Upgraded To “Buy” Rating By Analysts At Maxim Group.

Based on analysts offering 12 month price targets for AGRX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .

Detailed Share Price, Charts and News for Agile Therapeutics Inc [NASDAQ,AGRX]. Share Market Tools for Successful Investing. Global Share Market database ...

The Nasdaq Composite was lagging behind the other major stock indexes on Thursday as bond yields turned higher. The Nasdaq was down 0.3%, while the S&P 500 …PRINCETON, N.J., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced a partnership with Pandia Health, an online telehealth ...A high-level overview of Agile Therapeutics, Inc. (AGRX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Nov 30, 2023 · See the latest Agile Therapeutics Inc stock price (AGRX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. PRINCETON, N.J., March 15, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women's healthcare company, today announced that an abstract presenting data from two Phase 1 in ...Apr 26, 2023 · PRINCETON, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it has received a notification letter from the ... We closed out the fourth quarter 2021 with a net loss of $23.4 million or $0.20 per share compared to the net loss of $17.6 million or $0.20 per share for the comparable period in 2020. The full ...

Agile Therapeutics Inc (NASDAQ:AGRX) shares are down by over 99% in the last year and down almost 72% in the last three months. As of this writing, Agile Therapeutics shares are trading at above $0.38 (52-week range of $0.37 to $50.40), giving it a market capitalization of more than $15 million.Agile Therapeutics (AGRX) Q1 2022 Earnings Call Transcript. Mar 30, 2022. AGRX Sales Forecast. Next quarter’s sales forecast for AGRX is $9.20M with a range of $9.20M to $9.20M. The previous quarter’s sales results were $6.66M. AGRX beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 46.22% of the time in the same period.PRINCETON, N.J., July 23, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of ...Aug 9, 2023 · PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today reported financial results for the three months ended June 30 ... AGRX has an Altman Z-Score of -49.72 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for Agile Therapeutics, Inc. (AGRX) stock, including valuation metrics, financial numbers, share information and more.Agile Therapeutics Inc. (NASDAQ: AGRX) Agile Therapeutics Inc. (NASDAQ: AGRX) is a women's healthcare company dedicated to fulfilling the unmet health needs of today's women. Their product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a …

AGRX Latest Real Time Trades ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, and more asset classes. /March 26, 2023 at 11:25 PM · 10 min read. Agile Therapeutics, Inc. (NASDAQ: AGRX) Q4 2022 Earnings Call Transcript March 24, 2023. Operator: Good afternoon and welcome to the Agile Therapeutics ...

Aug 9, 2023 · PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today reported financial results for the three months ended June 30 ... PRINCETON, N.J., July 08, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and CEO Al Altomari will be participating in ...PRINCETON, N.J., Oct. 07, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it has reorganized and streamlined its executive ...PRINCETON, N.J., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today provided an update on Twirla for 2022 and its commercial plan for ...Company Plans to Appeal to the FDA’s Office of New Drugs. PRINCETON, N.J., July 24, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) (the “Company”), a women’s healthcare ...PRINCETON, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it has received a notification letter from the ...Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript November 9, 2023 Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58.

About Pre-Market Quotes. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. $0.277 -0.0029 -1.04%. NVIDIA Corporation Common Stock ...

AGRX Profile. Company Profile. Agile Therapeutics Inc. 500 College Road East. Suite 310. ... Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only.

Feb 27, 2023 · The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.” Agile Therapeutics Inc (NASDAQ:AGRX) shares are down by over 99% in the last year and down almost 72% in the last three months. As of this writing, Agile Therapeutics shares are trading at above $0.38 (52-week range of $0.37 to $50.40), giving it a market capitalization of more than $15 million.Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it will report first quarter 2021 financial results after the market close on Tuesday, May 4, 2021 as ...PRINCETON, N.J., May 12, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three months ended March 31, 2022 ...If you would like to register as a market maker in AGRX, contact Nasdaq Trading Operations at +1 212 231 5100. Email Alert Subscriptions: Nasdaq offers customers the ability to self select news delivery across various Nasdaq markets.PRINCETON, N.J., July 18, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the appointment of Dennis P. Reilly as Chief Financial ...A. The latest price target for Agile Therapeutics ( NASDAQ: AGRX) was reported by Maxim Group on Friday, September 22, 2023. The analyst firm set a price …The Nasdaq Composite was lagging behind the other major stock indexes on Thursday as bond yields turned higher. The Nasdaq was down 0.3%, while the S&P 500 …

Company now focused on completing plan to resubmit NDA in first half of 2019. PRINCETON, N.J., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women’s healthcare ...The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.Agile Therapeutics, Inc. (Agile or the Company) (NasdaqCM: NASDAQ: AGRX) is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Agile ...Agile Therapeutics (AGRX) Q1 2022 Earnings Call Transcript. Mar 30, 2022.Instagram:https://instagram. best stock trading alert servicetop rated stock analystshow to purchase a building with no moneyhow to buy bank of america stock The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.” opk sharesrvka Agile Therapeutics (NASDAQ:AGRX – Get Free Report) last released its quarterly earnings results on Thursday, November 9th. The specialty pharmaceutical company reported ($1.47) EPS for the quarter.26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report third quarter 2023 financial ... alfa romeo quad (NASDAQ: AGRX) forecast ROE is N/A, which is considered weak. What is AGRX's Price Target? According to 2 Wall Street analyst s that have issued a 1 year AGRX price target, the average AGRX price target is $8.50 , with the highest AGRX stock price forecast at $12.00 and the lowest AGRX stock price forecast at $5.00 . Agile Thrpe stock price live 2.1400, this page displays NASDAQ AGRX stock exchange data. View the AGRX premarket stock price ahead of the market session or assess the after hours quote.